














































































Preventing	 hospitalised	 patients	 from	 suffering	 adverse	 event	 (AEs)	 (unexpected	 cardiac,	 arrest,	
intensive	care	unit	admission,	surgery	or	death)	is	a	priority	in	healthcare.	Almost	50%	of	these	AEs,	




Focussing	 on	 variables	 that	 are	 routinely	 collected	 and	 electronically	 stored	 (blood	 test	 data,	 and	
administrative	data:	demographics,	date	and	method	of	admission,	and	co-morbidities),	along	with	
their	 trends,	 I	 have	 collected	data	on	~8	million	 admissions.	 I	 have	explained	how	 to	navigate	 the	






2. created	 four	 machine	 learning	 (ML)	 models	 that	 have	 the	 highest	 accuracy	 yet	 described	 for	
identifying	a	patient	at	risk	of	an	SAE,	while	at	the	same	time	capturing	the	majority	of	patients	
likely	to	die	(high	sensitivity).	These	models	ML-Dehydration,	ML-AKI,	ML-Admission,	and	ML-Two-
Tests,	 can	be	applied	 to	admissions	with	 limited	data,	 specific	 syndromes,	or	on	all	patients	 in	
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enabling	 immediate	 appropriate	 intervention,	would	prevent	 such	patient	deterioration.	 This	 early	
identification	needs	to	occur	in	the	resource	constrained	environment	of	the	healthcare	system	(e.g.	
it	must	not	require	expensive	additional	tests),	and	must	fit	in	with	existing	modes	and	processes	of	

















negligence,	 or	 poor-quality	 care.	 Although	 this	 does	 not	 necessarily	 mean	 that	 the	 events	 were	













government	 and	 patient	 reports4,5,8,9,10,11,12,	 and	 linked	 to	 reimbursement	 via	 quality	 improvement	
metrics13,14.	 The	UK,	National	 Institute	 for	Health	and	Care	Excellence	 (NICE),	National	Confidential	
Enquiry	 into	 Patient	 Outcome	 and	 Death	 (NCEPOD)	 and	 the	 Royal	 College	 of	 Physicians	 (RCP)	 all	
advocate	programmes	to	reduce	AE	frequency	through	the	early	recognition	of	patient	decline.	In	the	
USA,	as	a	condition	of	participation	in	the	Medicare	and	Medicaid	programmes,	Federal	regulations	
require	 that	 hospitals	 develop	 and	 maintain	 Quality	 Assessment	 and	 Performance	 Improvement	
(QAPI)	Programmes13.	As	a	part	of	their	QAPI	programmes,	hospitals	must	‘track	medical	errors	and	





































A	 significant	 proportion	 of	 hospitalised	 patients	 receive	 sub-optimal	 care7.	 This	 leads	 to	 increased	
mortality	and	morbidity.	Key	factors	in	this	sub-optimal	care	of	patients	are:	1)	the	lack	of	recognition	
of	the	seriousness	of	a	patient’s	condition	on	first	presentation	to	a	hospital;	2)	lack	of	recognition	of	a	










increased	 attention	 to	 patients	 exhibiting	 physiological	 abnormalities,	 as	 this	 is	 a	 marker	 of	
increased	mortality;	and	2)	Deployment	of	EWSCs	to	cover	all	hospitalised	patients.	These	EWSCs	
should	be	linked	to	a	RRT	that	was	appropriately	skilled	to	manage	the	deteriorating	patient.	
§ ‘Emergency	 Admissions:	 a	 journey	 in	 the	 right	 direction?’,	 published	 in	 20079,	 focussed	 on	
emergency	 admissions	 to	 hospitals.	 It	 highlighted	 that	 34.8%	of	 patients	 received	 substandard	















received	 substandard	 care.	 Among	 the	 report’s	 many	 recommendations	 was	 the	 robust	
implementation	 of	 ‘NICE	 Clinical	 Guidance	 50’,	 which	 are	 systems	 for	 recognising	 acutely	 ill	
patients.		




§ ‘Knowing	 the	Risk.	A	 review	of	 the	peri-operative	 care	of	 surgical	patients’,	published	 in	20114	
focussed	on	the	care	of	high-risk	surgical	patients.	Among	 its	key	findings	were:	a)	only	48%	of	
high-risk	 patients	 received	 care	 that	 was	 ‘good’;	 b)	 there	was	 a	 lack	 of	 consensus	 as	 to	what	
constitutes	high	peri-operative	risk	(a	recognition	problem);	c)	24%	of	patients	were	not	monitored	
by	an	early	warning	system;	and	d)	there	were	inadequate	pre-operative	interventions	to	optimise	
a	 patient’s	 nutritional	 and	 fluid	 status,	 resulting	 in	 poor	 outcomes	 for	 those	 cases	 where	




of	an	 in-hospital	cardiorespiratory	arrest’,	published	 in	201211,	 focussed	on	patients	who	had	a	
cardiac	arrest	in	hospital.	It	found	that	64%	of	cardiac	arrests	were	predictable,	with	warning	signs	
for	imminent	cardiac	arrest	present	in	75%	of	cases.	The	report	also	claimed	38%	of	cardiac	arrests	
were	avoidable.	Key	 factors	 in	 this	poor	antecedent	patient	care	were	 identified	as	 the	 lack	of	
‘recognition’	 and	 failure	 to	 escalate	 the	 care	 of	 these	 deteriorating	 patients.	 Again,	 the	
implementation	of	‘NICE	Clinical	Guidance	50’	was	one	of	the	key	recommendations.	

















detail	 in	 Section	 1.1.	 To	 deal	 specifically	 with	 1)	 monitoring	 and	 identification	 of	 the	 high-









of	 evidence	 of	 “failure	 to	 rescue”	with	 available	 clinical	 services,	 leading	 to	 AEs’16.	 As	 a	minimum	



























or	 rising	 EWSC	 value	 indicates	 a	 patient	 has	 or	 is	 deteriorating,	 while	 falling	 values	 indicate	 their	
improvement.	Thresholds	are	set,	where	if	a	patient’s	score	is	equal	to	or	above	a	certain	value,	specific	
actions	are	recommended,	from	increasing	the	frequency	of	recording	the	vital	signs	to	immediately	









EWSC	with	 appropriate	 escalation.7	 In	 2012,	 The	 RCP	 published	 the	 ‘National	 Early	Warning	 Score	































any	of	 these	 issues	arising	 in	my	ML	based	approach.	Although,	 vital-sign-based	EWSCs	have	been	





















(brpm)	 or	 >	 30	 brpm’,	 etc.	 Smith	 et	 al.	 compared	 80	 single-parameter	 EWSCs	 in	 9,987	 emergency	
medical	patients,	 and	demonstrated	variations	 in	 their	positive	predictive	 values	 (PPVs)	 to	 identify	
death	within	hospital,	which	ranged	from	13.5%	to	26.1%.20	Sensitivities	varied	from	7.3%	to	52.5%,	
with	 specificities	 ranging	 from	 69.1%	 to	 98.1%.	 The	 maximum	 positive	 predictive	 value	 (PPV)	 of	


















Warning	 Score,	 the	basis	 for	NEWS)	 and	MEWS	 (Modified	 Early	Warning	 Score),	were	 tested	on	 a	
dataset	of	1.15	million	vital	signs	obtained	from	42,230	admissions.25	The	mortality	rate	in	this	study	























monitor	 interventions.	 Although	 not	 regarded	 as	 an	 EWSC,	 blood	 test	 results	 are	 already	 used	 to	
identify	high-risk/deteriorating	patients.	Diagnoses	are	normally	made	by	interpreting	individual	blood	
results	and	their	trends,	ratios	of	different	blood	results,	simple	combinations	of	a	few	blood	results,	
























Most	blood	results	are	reported	with	a	reference	 interval	 (RI).	The	purpose	of	 the	RI	 is	 to	help	the	





















CDLs	 are	 based	 on	 the	 diagnostic	 question	 and	 are	 obtained	 from	 specific	 clinical	
















parameter	 vital-sign-based	 EWSCs,	 univariate	 analysis	 on	 individual	 blood	 tests	 provides	 poor	



















Dehydration	 is	a	 reduction	 in	 total	body	water.	This	can	occur	due	to	 reduced	 intake,	or	 increased	
losses.	A	reduction	in	the	intravascular	volume	without	a	reduction	in	total	body	water,	which	occurs	
when	intravascular	water	moves	into	the	third	spaces	(interstitial,	peritoneum,	etc.),	is	intravascular	
hypovolaemia.	 Most	 clinical	 measurements	 of	 dehydration	 rely	 on	 sampling	 of	 the	 intravascular	
plasma	and	thus	cannot	normally	differentiate	between	the	two.34	Understanding	the	specific	type	of	
















creatinine.	 In	 individuals	who	are	 	dehydrated,	urea	concentrations	 in	 the	 renal	medulla	 (and	 thus	
plasma)	rise37	whilst	creatinine	continues	to	be	freely	filtered.	This	results	in	a	rise	in	the	Ur:Cr.	A	Ur:Cr	
>80	 mmol/L:mmol/L	 (BUN:CR	 >20	 mg/l:mg/l))	 has	 been	 traditionally	 considered	 a	 marker	 of	
dehydration	(or	intravascular	volume	depletion).38,39	However,	Ur:Cr	may	rise	for	other	reasons:	urea	
for	 instance,	 also	 rises	 in	 hypercatabolic	 states	 (sepsis,	major	 surgery,	 starvation)40;	with	 the	 large	
‘blood	 protein	 meal’	 of	 an	 upper	 gastrointestinal	 bleed41,42;	 or	 with	 high-dose	 glucocorticoid	





Hospitalised	 patients	 are	 at	 risk	 of	 dehydration,	 due	 to	 impaired	 intake	 (resulting	 from	 cerebral,	




Dehydration	 also	 leads	 to	 renal	 hypoperfusion,	 and	 plays	 an	 important	 pathogenic	 role	 in	 the	
development	 of	 AKI.5,52	 Specifically,	 a	 raised	Ur:Cr	 is	 associated	with	 an	 increased	 risk	 of	 death	 in	
patients	with	AKI53	and	in	those	on	long-term	dialysis.54,55	In	stroke,	it	is	associated	with	early	clinical	
deterioration56,	 impaired	 functional	 outcome57,58,	 thromboembolism37	 and	 mortality57,58.	 Elevated	
Ur:Cr	 is	 also	 an	 independent	 marker	 of	 mortality	 in	 critical	 care40,59,	 heart	 failure60,	 myocardial	








The	 impact	 of	 dehydration	 on	 healthcare	 costs	 and	 outcomes	 is	 causing	 increasing	 concern	 to	
England’s	 Care	 Quality	 Commission69,	 patient	 associations70	 and	 the	 Parliamentary	 Ombudsman71,	
with	such	concerns	being	echoed	 in	recent	 independent	 inquiries72	and	 in	the	media.73,74,75,76,77	The	
NICE	has	recently	issued	clinical	guidelines	in	an	effort	to	improve	the	prevention	and	management	of	
dehydration	and	AKI.6,78	However,	despite	concerns	over	the	clinical	 impact	of	dehydration	and	the	
awareness	 that	 it	 may	 be	 more	 commonplace	 than	 expected,	 the	 true	 current	 prevalence	 of	














Thus,	 two	 routinely	 performed	 blood	 tests,	 whether	 viewed	 independently	 or	 interpreted	 in	
conjunction,	provide	significant	insight	into	the	condition	of	the	majority	of	hospitalised	patients.	The	
results	of	these	tests,	and	in	particular	their	ratio,	are	strongly	associated	with	in-hospital	mortality.	It	











including	 but	 not	 limited	 to	 kidney	 diseases	 (e.g.	 acute	 interstitial	 nephritis;	 acute	 glomerular	 and	
vasculitic	 renal	 diseases;	 ischaemia,	 toxic	 injury),	 extra-renal	 pathology	 (for	 example,	 pre-renal	
azotaemia,	acute	post-renal	obstructive	nephropathy,	sepsis).	More	than	one	of	these	conditions	may	
coexist	 in	 the	 same	 patient.	 In	 2012,	 to	 harmonise	 the	 detection	 and	 treatment	 of	 AKI,	 a	 rise	 in	
patient’s	serum	creatinine	and	a	fall	in	their	urine	output	measures	were	used	by	the	Kidney	Disease:	




amongst	UK	 hospital	 admissions.79	 AKI	 is	 also	 associated	with	 increased	 risk	 of	 death85,	 prolonged	
hospitalisation86,	requirement	for	renal	replacement	therapy87,	or	the	development	of	chronic	kidney	
disease.88	The	associated	health	care	costs	of	AKI	exceed	£1	billion	per	year	in	the	UK.79	Over	50%	of	






In	 response,	 initiatives	 throughout	 the	 world	 have	 attempted	 to	 promote	 AKI	 recognition	 and	




KDIGO,	 Table	 1.1)	 in	 hospital	 laboratory	 information-management	 systems	 (NHSE-AKI	 algorithm,	
Figure	1.8).	 The	NHSE-AKI	 algorithm	compares	 the	 current	 creatinine	 result	of	 a	patient	with	 their	
previous	results,	to	determine	whether	a	significant	rise	has	occurred.	Specifically,	the	current	result	
is	 compared	 to	 a	 ‘baseline	 creatinine’	 value,	 which	 is	 calculated	 as	 either	 the	 patient’s	 minimum	









<	 0.5ml/kg/hr	 for	 6-
12	hours	
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modify	 the	 care	 a	 patient	 receives,	 is	 that	 of	 perioperative	 medicine.	 For	 example,	 for	 patients	




demographic,	 co-morbidities,	 lifestyle	 questions,	 surgical	 questions,	 vital-sign	 and	 laboratory	










































































































































































































The	 AUROC	 for	 these	multi-parameter	models	 range	 from	 76.7%91	 to	 90%93.	 However,	when	 only	
laboratory	and	demographic	variables	are	used	as	predictor	variables	(i.e.	vital	signs	are	excluded),	the	






Overall,	 a	 range	 of	 multi-parameter	 models	 have	 been	 built,	 some	 of	 which	 have	 reasonable	












morbidities,	 or	 day	 and	month	 of	 admission.	 All	 of	 these	 factors	may	 have	 an	 influence	 on	 a	
patient’s	health	status.	
§ The	 majority	 of	 algorithms	 built	 for	 surgical	 perioperative	 outcomes,	 and	 the	 various	 EWSCs,	
whether	they	are	vital-sign-based	or	laboratory-based,	use	variants	of	logistic	regression	to	create	
their	respective	models.	The	key	problem	with	this	approach	is	that	the	models	assume	that	the	
dependent	 variables	 (the	 variables	 used	 to	 predict	 the	 outcome,	 such	 as	 heart	 rate,	 etc.)	 are	
completely	 independent	 from	each	other.	However,	 this	 is	 not	 the	 case;	 for	 example,	 age	and	
creatinine	could	be	 inversely	correlated,	as	 increasing	age	 is	associated	with	decreasing	muscle	
mass97,	and	thus	with	falls	in	creatinine.98	Similarly,	many	variables	rise	or	fall	together	in	certain	
pathological	 processes,	 such	 as	 dehydration	 (urea,	 creatinine	 and	possibly	 sodium)	 and	 severe	
malnutrition	 (falls	 in	 both	 haemoglobin	 and	 albumin,	 and	 rises	 or	 falls	 in	 mean	 cell	 volume,	



















































§ Unsupervised	 learning:	 A	 computer	 system	 is	 provided	with	 data,	 but	 neither	 a	 structure	 nor	





























building	 decision	 trees	 that	 combined	 randomised	 optimisation	 at	 each	 node	 with	 bootstrap	
aggregating	(bagging).	
1.5.2	Gradient	Boosting		















to	 complete.	One	popular	 software	 toolkit	 is	 ‘H2O’.105	 It	 is	 implemented	 in	 the	 JAVA	programming	
language,	and	has	a	version	that	works	on	the	two	most	common	technologies	in	the	‘big	data’	space-	
‘Hadoop’	and	‘Spark’,	thus	making	it	‘futureproof’	for	at	least	the	near	future.	H2O	has	implemented	





2. Data	pre-processing:	The	process	of	ensuring	that	the	collected	data	 is	clean	and	consistent.	 It	
















order	 to	 enhance	 the	 dataset	 and	 improve	 the	 creation	 of	 accurate	 predictive	 models.	 For	
example,	patient	admission	data	could	be	enhanced	by	creating	a	feature	(variable)	that	is	the	day	
of	 admission	 (Mon–Sun),	 and	blood	 result	data	 could	be	enhanced	by	 calculating	 the	absolute	
difference	between	consecutive	blood	results.	






model	 the	data.	These	parameters	determine	 ‘higher	 level’	properties	of	 the	model	such	as	 its	
complexity	and	how	fast	it	should	‘learn’.	Grid	search	is	the	traditional	method	of	hyper-parameter	
optimisation;	 sometimes	 referred	 to	 as	 parameter	 sweep,	 it	 simply	 refers	 to	 building	multiple	








distinct	 from	 the	 train	dataset	 is	 required.	Rather	 than	 just	 splitting	 the	 train	dataset	 into	 two	
parts,	n-fold	cross-validation	offers	an	alternative.	For	n-fold	cross-validation	where	n	=	5,	the	train	
dataset	is	split	into	five	parts,	four	of	which	are	used	to	train	the	model,	while	the	fifth	part	is	used	
to	 test	 it.	 This	 process	 is	 repeated	 a	minimum	 of	 five	 times,	 with	 the	model	 iteratively	 being	
improved,	especially	for	generalisation.	The	mean	performance	metrics	(AUROC,	logloss)	of	all	the	
models	 provide	 an	 indication	 of	 the	 final	model’s	 theoretical	 performance	 on	 an	 independent	
dataset.	






























































The	 data	 I	 required	 for	 my	 study	 included	 administrative	 information:	 patient	 demographics,	
admission	 and	 discharge	 dates,	 methods	 of	 admission,	 as	 well	 as	 information	 relating	 to	 patient	
diagnoses	 and	 treatments	 in-hospital.	 There	 are	 many	 electronic	 sources	 in	 a	 hospital	 that	 store	
patient	information,	ranging	from	the	electronic	health	record	(EHR),	patient	administration	system	





































Admitted	Patient	Care	 (day	 case	and	 inpatient)	activity	 taking	place	 in	any	of	 the	 following:	acute,	
community	 or	 mental	 health	 NHS	 trusts,	 other	 NHS	 hospitals,	 non-NHS	 hospitals,	 and	 non-NHS	
hospitals	or	institutions	where	the	care	delivered	is	NHS-funded.	The	complete	list	of	CDS	datasets	is	




of	 these	 teams	varies	by	organisation,	and	 I	did	not	 find	a	standard	organisational	 framework	 that	
dictates	who	collects,	validates,	transforms	and	submits	the	data	to	Health	and	Social	Care	Information	
Centre	(HSCIC,	recently	restructured	into	a	new	organisation	NHS	Digital).	Frequently,	different	tasks	
are	 undertaken	 by	 different	 departments	 within	 the	 organisation,	 with	 some	 tasks	 also	 being	
outsourced	to	commercial	entities.	This	results	 in	multiple	different	workflows	within	and	between	
different	organisations,	 for	what	 is	a	mandatory	and	standardised	national	data	submission.	 In	one	
organisation,	a	common	example	would	be	as	follows:	post	discharge	of	a	patient	from	hospital,	the	
patient’s	 notes	 would	 be	 transferred	 to	 the	 clinical	 coding	 team,	 who	 would	 examine	 these	 to	
	
45	
determine	 not	 only	what	 diseases	 the	 patient	 suffers	 from	 chronically,	 but	 also	 any	 specific	 acute	
conditions	 that	were	 treated	 in	 their	most	 recent	hospitalisation.	This	 information	would	 form	 the	
basis	of	the	patient’s	ICD10	(International	Classification	of	Diseases	Version	10),	Treatment	Function	
and	Main	 Specialty	 codes.	 However,	 in	 another	 organisation,	 the	 admitting	 or	 discharging	 doctor	
would	be	responsible	for	listing	all	the	relevant	patient’s	diseases,	enabling	the	coding	team	to	easily	








The	 data	 for	 each	 patient	 episode	 (row)	 in	 this	 dataset	 is	 usually	 compiled	 after	 the	 patient	 has	
completed	their	‘episode’	of	care	in	their	Secondary	Care	Organisation.	In	the	context	of	this	research	




transferred	 to	 another	 consultant,	 a	 new	 episode	 begins.	 The	 data	 elements	 that	 comprise	 the	
CDS.APC	dataset	are	extremely	comprehensive,	though	not	all	the	fields	present	are	necessarily	filled.	




tables.	 These	 are	 a	 description	 of	 the	 raw	 data,	 and	 where	 mentioned,	 the	 equivalent	
anonymised/grouped	data	that	was	provided	by	the	collaborating	NHS	Trusts	for	this	project.	







§ ICD10	 codes:	 These	 are	 listed	 as	 comprising	 one	 primary	 diagnosis,	 and	 up	 to	 fifty	 secondary	
diagnoses.	 The	 order	 of	 the	 diagnoses	 is	 not	 usually	 based	 on	 the	 guidance	 by	 healthcare	
	
46	
professionals	 (based	 on	 discussion	 with	 the	 clinical	 coders),	 but	 is	 usually	 ordered	 so	 as	 to	
maximise	 the	Health	 Care	 Resource	Group	Code,	 and	 thus	 generate	maximum	 income	 for	 the	
Trust.	The	International	Statistical	Classification	of	Diseases	and	Related	Health	Problems	(ICD)	is	




Kingdom	 government	 purposes.	 The	 full	 list	 of	 ICD-10	 codes	 is	 available	 at:	
‘http://apps.who.int/classifications/icd10/browse/2010/en’.	




number	 of	 amendments,	 and	 a	 consolidated	 version	 was	 reproduced	 in	 1990.	 The	 OPCS	
Classification	of	 Interventions	and	Procedures	 (OPCS-4.2)	was	substantially	enhanced	to	ensure	
that	modern	clinical	practice	was	represented	appropriately	within	the	classification,	and	a	new	
version	was	 implemented	 in	 2006,	 titled	 ‘OPCS	 Classification	 of	 Interventions	 and	 Procedures’	
(OPCS-4.3),	with	a	commitment	to	undertake	an	annual	review	and	potential	update.	The	current	





for	 individual	organs,	was	broken	 in	OPCS-4.3	because	of	 limited	capacity.	A	 full	 list	of	OPVSv4	
codes	is	available	at	‘http://systems.hscic.gov.uk/data/clinicalcoding/codingstandards/opcs4’.	
§ CCMDS:	 The	 data	 in	 the	 Critical	 Care	 Minimum	 Data	 Set	 primarily	 relates	 to	 any	 part	 of	 the	











































































































































































































































































































Upper	reference	range	 Numerical	value	 Same	 Majority	missing	






























































designed	 for	 large-scale	 data	 extraction	 or	 querying.	 It	 is	 understandable	 that	 in	 a	 critical	 system,	
processes	 and	 queries	 that	 are	 not	 related	 to	 the	 immediate	 task	 of	 live	 sample	 and	 result	
management	do	not	 interfere	with	the	running	of	a	 laboratory.	However,	 the	difficulty	and	cost	of	
customising	 the	 LIMS	 for	 additional	 tasks	 impedes	 research,	 and	 ultimately	 limits	 the	 further	
integration	of	pathology	results	into	clinical	pathways.	LIMS	providers	frequently	charge	substantial	
consultancy	fees	for	these	‘additional’	services,	such	as	data	extraction.	In	fact,	during	the	course	of	





same	 test	 performed	 on	 the	 same	 type	 of	 sample	 may	 be	 referred	 to	 differently	 in	 different	
organisations.		
‘Most	 laboratories	and	clinical	services	use	HL7	(the	medical	messaging	standard)	to	
send	 their	 results	 electronically	 from	 their	 reporting	 systems	 to	 their	 care	 systems.	
However,	 the	 tests	 in	 these	 messages	 are	 identified	 by	 means	 of	 their	 internal,	
idiosyncratic	 code	 values.	 As	 a	 result,	 the	 receiving	 care	 system	 cannot	 fully	





‘Up	until	now,	 there	has	been	no	way	of	 reporting	pathology	 results	 in	a	consistent,	
standardised	way	across	the	country.	Different	names	in	different	settings	could	have	
meant	the	same	or	different	things.	This	has	led	to	problems.	A	patient	may	have	a	test	








the	 LOINC	 committee	 in	 1994,	 whose	 task	 was	 to	 develop	 a	 common	 terminology	 for	 laboratory	




























end	 user,	 either	 the	 healthcare	 professional	 looking	 after	 the	 patient,	 or	 indeed	 the	 patient	
him/herself,	they	both	interpret	a	pathology	result	as	being	absolute	and	comparable,	regardless	of	
where	it	was	obtained.	In	reality,	the	result	is	only	bound	by	the	quality	assurance	standard	of	the	local	












of	 Helsinki.112	 This	 is	 a	 statement	 of	 the	 ethical	 principles	 for	 medical	 research	 involving	 human	
subjects,	 including	 research	 on	 identifiable	material	 and	 data.	 In	 the	UK,	 the	 research	 governance	
framework	for	health	and	social	care113	outlines	the	principles	of	good	governance	that	apply	to	all	








§ Healthcare	 data	 is	 primarily	 created	 for	 one	 specific	 purpose:	 the	 direct	 care	 of	 an	 individual	
patient.	There	are,	however,	a	multitude	of	secondary	uses	 (not	 for	direct	patient	care)	of	 this	
data.	Capturing	 the	details	of	a	patient,	 their	co-morbidities,	 their	acute	condition,	 the	specific	
procedures	and	interventions	carried	out	in	their	care,	and	various	administrative	details,	allows	a	
patient’s	 medical	 interventions	 to	 be	 categorised,	 costed	 and	 appropriately	 reimbursed.	
Reimbursement	to	the	healthcare	establishment	(and	individuals)	for	providing	medical	care	is	in	
fact	 the	 leading	 use	 of	 such	 data,	 after	 its	 utilisation	 for	 direct	 patient	 care.	 Whether	 this	





of	 the	 patient,	 is	 utilised	 for	 another;	 specifically,	 research.	 There	 is,	 on	 the	 surface,	 conflicting	
guidance	 and	 advice	 from	 the	 UK	 Health	 Research	 Authority	 (HRA)	 (www.hra.nhs.uk).	 The	 HRA	
guidance	states	that,	regarding	NHS	Research,		
‘Research	limited	to	secondary	use	of	information	previously	collected	in	the	course	of	




















data	 needs	 REC	 approval	 (http://hra-decisiontools.org.uk/ethics/)	makes	 its	 decision	 solely	 on	 the	












Researchers,	 sponsors	 and	 organisations	 where	 the	 research	 is	 carried	 out	 remain	
responsible	 for	 making	 sure	 the	 research	 is	 conducted	 in	 accordance	 with	 the	
requirements	of	law,	relevant	regulators	and	guidance,	e.g.	the	Data	Protection	Act,	the	
Codes	 of	 Practice	 issued	 under	 the	Mental	 Capacity	 Act	 and	 Human	 Tissue	 Act,	 or	
recognised	standards	of	Good	Clinical	Practice.’		










First	 of	 all,	we	 need	 to	 explore	 the	 precise	 definition	 of	 anonymised	 data.	 The	word	 ‘anonymous’	
comes	via	late	Latin	from	the	Greek	anōnumos	'nameless'	(from	an-	'without'	+	onoma	'name').	It	refers	
to	a	person,	or	in	this	case	data,	that	cannot	be	identified	or	attributed	to	a	specific	name	(person).	
However,	 the	 problem	 with	 the	 concept	 of	 anonymised	 data	 is	 that	 there	 must	 be	 sufficient	
obfuscation	of	the	data	to	ensure	that	any	individual	in	the	dataset	cannot	be	identified	directly	from	
the	 data	 itself,	 but	 it	 may	 not	 be	 possible	 to	 ensure	 this	 if	 the	 data	 is	 combined	 with	 any	 other	
information.	 The	 UK	 Information	 Commissioners	 Office	 (ICO)	 has	 produced	 a	 code	 of	 practice,	
‘Anonymisation:	 managing	 data	 protection	 risk’	 (‘the	 code’),	 to	 govern	 the	 anonymisation	 of	
identifiable	 data.116	 The	 ICO	 acknowledges	 within	 ‘the	 code’	 the	 risk	 of	 re-identification,	 and,	
dependent	on	the	potential	consequences	of	such	re-identification,	recommends	either	 (1)	 limiting	
access	to	this	‘grey	data’,	along	with	implementing	robust	governance	processes;	(2)	more	rigorous	









code	 to	 the	 point	 where	 determining	 individual	 identities	 from	 the	 data	 is	 unlikely,	 requiring	
unreasonable	effort.	The	data	does	not	require	a	legal	or	contractual	basis	for	processing	it,	and	
can	be	publicly	disclosed.	This	data	is	called	‘de-identified	data	for	publication’.	
§ Personal	 confidential	data:	 This	 is	data	 in	which	 individuals	are	clearly	 identified,	or	are	easily	
identifiable.	This	data	should	not	be	processed	without	a	clear	legal	basis.	Personal	confidential	
data	should	only	be	disclosed	with	consent	or	under	statute,	and	any	disclosure	must	always	be	













However,	 nowhere	 is	 the	 distinction	 clearly	 defined	 between	 what	 precisely	 constitutes	 the	 truly	
anonymised	dataset	and	this	grey	area	of	data	that	could	potentially,	at	some	point	in	the	future,	be	
de-anonymised.	 There	 are	 numerous	mechanisms	 to	 perform	 this	 process,	 one	 of	 which	 involves	


















‘Medical	 research	 relies	 on	 people’s	 health	 data	 to	 develop	 new	 medicines	 and	
treatments	 to	 transform	 and	 save	 people’s	 lives.	 Therefore,	 the	 Government	 is	
committed	to	do	all	it	can	to	encourage	people	to	allow	their	data	and	information	to	
be	used	to	help	realise	the	opportunities	for	further	progress.	There	is	a	need	to	continue	







the	 principles	 of	 ethics	 and	data	 protection	 for	 large	 patient	 datasets	 is	 still	 not	 being	 adequately	
addressed.	These	problems	are	impeding	both	medical	research	and	the	linkage	of	patient	data	across	






















data	makes	 it	 vulnerable	 to	being	 ‘hacked’,	 and	 thus	private	patient	 data	 is	 no	 longer	 private	 and	
becomes	 freely	 available.	 For	 all	 of	 the	above	 reasons,	 the	Care.Data	 initiative	 remained	 in	 a	pilot	
















Hence,	 in	 accordance	 with	 guidance	 (ethical	 and	 legal),	 and	 based	 on	 both	mine	 and	 that	 of	 my	
university’s	 information	 governance	 lead’s	 interpretation,	 of	 the	 relevant	 regulations/laws,	 I	 have	
regarded	and	communicated	my	study	data	as	being	of	the	category:	 ‘data	for	 limited	disclosure’.	I	
applied	 for	and	received	NHS	Research	Ethics	Committee	approval	 (REC	No:	13/WS/0243).	 I	 liaised	
with	every	Trust’s	research	and	information	governance	teams,	not	only	to	clarify	the	purpose	of	the	
project,	 but	 also	 to	 reassure	 them	 regarding	 the	 study’s	 compliance	 with	 the	 principles	 of	 data	
protection	and	 information	governance.	 I	 clearly	 stated	 that	 the	data	 they	were	providing	was	not	
going	 to	 be	 regarded	 as	 a	 freely	 usable	 anonymised	 dataset,	 and	 absolutely	 no	 attempt	 to	 de-
anonymise	 the	 data	would	 be	made.	 As	 the	 Information	Governance	 Review	 118	was	 published	 as	






















§ Controls	 over	 the	 ability	 to	 bring	 other	 data	 into	 the	 environment,	 allowing	 the	 risk	 of	 re-
identification	by	linkage	or	association	to	be	managed:	A	firm	commitment	was	made	to	all	study	






§ Restriction	on	 the	disclosure	of	 the	data:	A	 firm	commitment	was	made	 to	all	 study	sites	and	
written	into	all	the	study	documents,	guaranteeing	that	‘The	data	will	not	be	shared	with	any	other	
investigators’.	
§ Prohibition	 on	 any	 attempt	 at	 re-identification	 and	 measures	 for	 the	 destruction	 of	 any	





so	 forth)	 with	 data	 protection	 needs.	 Some	 of	 the	 specific	 measures	 stated	 in	 the	 various	























o Partial	 removal	 of	 postcodes.	 Only	 the	 first	 4	 characters	 (including	 spaces)	 would	 be	
requested,	 thus	 placing	 each	 partial	 postcode	 within	 a	 group	 of	 approximately	 8,600	





























to	 determine	 its	 decryption	 key	 or	 passphrase	 by	 trying	 hundreds	 or	 sometimes	millions	 of	 likely	
possibilities,	 such	 as	 words	 in	 a	 dictionary’.	 A	 pre-computed	 rainbow	 table	 attack	 is	 similar	 to	 a	
dictionary	attack,	but	in	this	case	the	dictionary	is	already	associated	with	pre-computed	hash	values.	
This	method	 is	void	 if	a	SALT	 is	added	 to	 the	data	prior	 to	 the	hash	 function	being	employed.	 It	 is	

















The	 documents	 relating	 to	 the	 study	 included	 the	 Protocol	 (Appendix	 2),	 the	 Research	 Ethics	









medical	 profession,	 the	 healthcare	 providers,	 and	 the	 government,	 as	 well	 as	 the	 introduction	 of	





out	 research	 which	 would	 comply	 with	 both	 ethical	 and	 legal	 requirements.	 This	 approach	 is	 of	









4. Approaching	 individual	 NHS	 Trusts	 to	 encourage	 adoption	 of	 the	 study	 in	 their	 respective	
organisations	 (which	entailed	discussions	and	approval	of	 the	 local	 research	and	development,	











study’s	CRN	approval	 arrived	approximately	nine	months	after	ethical	 clearance	was	 received.	The	
specific	advantages	of	CRN	and	portfolio	inclusion	for	my	study	were	that	these	offered:	1)	support	for	
the	 local	NHS	 sites	 to	 assess	 and	ultimately	 approve	 the	 study	by	providing	 access	 to	CRN-funded	





























a. Identification	 of	 the	 relevant	 information	 teams	 at	 each	 NHS	 hospital,	 these	 being	

















h. Most	 NHS	 Trusts	 were	 unable	 to	 access	 their	 datasets	 from	 as	 long	 ago	 as	 2005	 (the	











































and	 5)	 variable	 selection:	 selecting	 the	 specific	 variables	 needed	 to	 build	 a	 model.	 The	 feature	
engineering	and	variable	selection	for	each	model	will	be	described	in	the	relevant	chapters	for	each	










the	variables	within	 the	 files	were	either	placed	 in	 fixed-width	slots	 (i.e.	variable	one	occupied	 the	
space	 for	 characters	1–10;	 variable	 two,	 characters	11–20,	etc.),	 or	were	 separated	by	 fixed-width	
empty	 spaces	 (‘tabs’).	 The	 initial	 import	 of	 the	 data	was	 performed	 using	 a	 ‘catch-all’	 philosophy,	
where	 all	 the	 data	were	 imported	 into	 a	 text	 format	 that	 allowed	 for	 various	 types	 of	 characters	
(‘varchar’).	Thus	dates,	text	and	numbers	were	all	regarded	as	strings	of	characters.	Despite	this	catch-
all	 approach	 with	 no	 initial	 quality	 control,	 there	 were	 still	 issues	 with	 the	 data	 ingestion.	 Most	








and	 laborious	 process,	 as	 not	 only	 did	 the	 data	 files	 differ	 between	NHS	 Trusts,	 but	when	 a	 Trust	
consisted	of	multiple	hospitals,	the	data	was	commonly	provided	on	a	per	hospital	basis,	each	with	its	









and	requesting	 the	data	 in	 these	national	 formats,	none	of	 the	NHS	Trusts	who	participated	 in	my	
study	provided	me	with	this	data	in	the	respective	national	formats.	In	fact,	every	NHS	Trust	provided	
the	data	using	its	own	customised	format.	These	customised	formats	used	different	names	not	only	




of	 a	 national	 standard),	 seems	 to	 be	 the	 path	 of	 least	 resistance	within	 NHS	 Trusts.	 Consider	 the	

























as	 SQL	 (standard	 query	 language),	 but	 have	 customised	 and	 proprietary	 syntax,	 adding	 an	
additional	barrier	to	data	access	and	extraction.	






4. Finally,	 procedures	 to	 procure	 and	 maintain	 the	 myriad	 clinical	 information	 systems	 have	
traditionally	been	conducted	haphazardly	(in	my	opinion)	within	the	NHS.	As	a	result,	although	
the	money	 spent	 on	 these	 systems	 is	 substantial,	 the	 system	obtained	 is	 either	 not	 fit	 for	
purpose,	or	the	contracts	signed	do	not	allow	any	flexibility	without	massive	additional	costs.	
Therefore,	when	clinical	requirements	change,	the	IT	systems	are	not	appropriately	modified;	
instead,	 inappropriate	 (and	 cheap)	 modifications	 are	 employed	 to	 enable	 increased	
functionality.	 This	 creates	 an	 IT	 environment	 within	 an	 NHS	 Trust	 that	 includes	 multiple	




To	 return	 to	my	data:	post	data	 ingestion,	 I	performed	a	number	of	 steps,	both	 to	 check	 the	data	
quality	and	to	transform	the	data	to	my	standard	format.	I	designed	a	series	of	queries	(‘scripts’)	to	
perform	these	tasks.	These	tasks	were:	
1. To	confirm	the	anonymisation	of	 the	 identifiable	 fields.	 If	anonymisation	was	 in	doubt,	another	
round	of	‘hashing’	was	carried	out	on	these	fields,	across	the	linked	data.	
2. To	confirm	the	deletion	of	non-requested	fields	(especially	identifiable	fields).	If	the	presence	of	any	






across	 these	 two	were	 found.	After	 liaising	with	 the	NHS	Trusts	 concerned,	 the	most	 common	
cause	was	inappropriate	anonymisation:	i.e.	different	anonymisation	algorithms	were	employed	
to	 anonymise	 or	 ‘hash’	 the	 same	 identifiers	 in	 the	 two	 datasets	 (CDS.APC	 and	 blood	 results),	
resulting	 in	 different	 hashed	 values	 which	 did	 not	 match.	 Once	 identified,	 the	 NHS	 Trusts	
appropriately	anonymised	the	datasets	and	provided	them	to	me.	
4. A	database	‘View’	(method	of	transforming	data	and	visualising	the	new	format),	was	created	for	








5. Once	 these	 Views	 were	 created,	 the	 identifiers	 across	 the	 CDS.APC	 and	 blood	 results	 were	
rehashed	and	then	replaced	sequentially	by	an	 index	number,	beginning	at	 ‘1’.	Finally,	a	coded	












































were	 rows	of	data	where	either	of	 these	values	was	missing,	or	where	 the	discharge	date	was	
before	the	admission	date.	In	addition,	all	rows	of	data	where	the	discharge	date	was	>183	days	
(more	 than	 six	months)	 from	 the	 admission	date	were	 also	 deleted.	 This	was	 because	 I	 found	
lengths	of	stays	of	five	years	or	more	for	hundreds	of	patients,	many	with	the	same	discharge	date	
(implying	that	a	default	discharge	date	had	been	inserted	when	none	was	present;	this	is	poor	but	










the	 remit	of	my	project,	but	also	 to	 retain	past	medical	history	data,	 I	deleted	 the	data	 for	all	
patients	born	on	or	after	September	1995;	eighteen	years	before	the	start	of	my	project.	Thus,	
only	adult	patients,	according	to	the	approved	data	ethics	for	my	project,	were	 included	 in	the	
investigation.	 However,	 I	 also	 took	 the	 additional	 step	 of	 including	 only	 patients	 who	 were	
eighteen	years	or	over	on	the	date	of	admission	to	hospital	in	my	subsequent	analyses	(Chapters	
3	to	5).	Most	NHS	Trusts	were	not	able	to	perform	this	filtering	of	the	data	prior	to	transfer.	




















Apart	 from	various	specific	data	cleaning	 tasks	described	above,	 I	also	deleted	all	blood	results	 for	
which	where	there	were	no	matching	patient	 identifiers	 in	 the	CDS.APC	dataset.	These	blood	tests	









I	 believe	 the	 reason	 for	 my	 success	 for	 carrying	 out	 such	 a	 large-scale	 data	 project,	 hinge	 on	 a	
combination	of	my	clinical	and	technical	expertise,	and	following	the	principles	of	these	key	lessons.		
A. The	 ethical	 and	 legal	 requirements	 are	 not	 barriers	 to	 make	 life	 difficult	 for	 researchers,	 but	
necessary	 safeguards	 to	maintain	 trust.	 These	 ethical/legal	 requirements	 are	 complicated,	 and	




the	 ethical/legal	 framework	 rather	 than	 simply	 the	 guidance	 text.	 Thus,	 when	 appropriate	








D. Healthcare	 IT	 systems	 are	 generally	 proprietary	 systems,	 which	 are	 based	 both	 on	 older	
technology	frameworks	and	have	limited	access	to	the	end	user	(customer).	This	makes	accessing	
the	 data	 that	 resides	 in	 them	 difficult.	 Engagement	 with	 the	 software	 provider	 is	 frequently	
necessary	 to	 understand	 these	 proprietary	 systems,	 and	 to	 enable	 technical	 support	 to	 the	
healthcare	IT	teams.	Data	access	from	certain	IT	systems	will	be	unfeasible	either	due	to	technical	
issues,	or	because	the	software	provider	will	demand	a	large	payment	to	enable	such	data	access.		
E. Healthcare	 data	 resides	 in	 multiple	 IT	 systems,	 and	 is	 frequently	 collected	 in	 duplicate	 from	
multiple	sources.	In	cases	where	data	access	from	a	certain	healthcare	IT	system	is	unfeasible,	this	
data	may	be	accessible	from	another	data	repository	within	the	hospital.	
F. Healthcare	 data	 does	 not	 adhere	 to	 published	 international,	 national	 or	 even	 local	 standards.	
Demanding	data	 in	a	 format	 (schema	and	quality)	 suitable	 for	 the	 researcher	 is	quick	 route	 to	













Made	 up	 of	 two	 of	 the	 blood	 tests	 most	 commonly	 performed	 in	 hospital	 are	 for	 urea	 (Ur)	 and	




2)	 a	Ur:Cr	>	80	has	historically	been	used	 to	define	dehydration.	 The	availability	of	 these	 two	 test	







To	 investigate	 outcome	 (mortality	 and	 length	 of	 stay)	 associated	 with	 known	 models	 of	 disease.	
Specifically,	for	dehydration,	to	explore		
I. The	significance	of	dehydration	as	measured	by	Ur:Cr	on	outcome	





































2. Continuous	analysis:	Ur:Cr	was	plotted	against	 in-hospital	mortality,	 for	each	 set	of	 a	patient’s	
blood	tests	 (admission	 to	 last	blood	test	before	discharge	or	death).	The	percentage	change	 in	
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Ur:Cr	 from	 admission	 to	 last	 test	was	 calculated.	 Heatmaps	 of	 age	 vs	 Ur:Cr	 vs	mortality	were	
plotted	for	both	the	admission	and	the	last	blood	tests,	to	visualise	the	influence	of	age.	The	last	
set	of	blood	results	were	used	(Ur:Crlast)	as	these	could	be	considered	to	be	either	the	optimum,	
when	 a	 patient	 was	 discharged;	 or	 the	 worst,	 just	 prior	 to	 death.	 To	 highlight	 the	 complex	
relationship	between	all	 the	available	 variables	 (Table	3.1),	 and	 their	 change	 (upto	 the	 second	
blood	test)	and	in-hospital	mortality,	I	built	a	RF	ML	model	(ML-Dehydration).	The	ML-Dehydration	
model	 was	 built	 using	 5-fold	 cross-validation.	 The	 hyper-parameters	 of	 the	 model	 were	
determined	via	a	grid	search.	This	analytical	framework	was	applied	to	70%	of	patients	(training	
dataset).	 The	 final	 model	 was	 tested	 on	 the	 remaining	 30%	 (testing	 dataset).	 Area	 under	 the	
receiver	operator	curve	(AUROC)	was	calculated	for	the	whole	model.	From	the	trained	model,	a	
threshold	was	set	to	classify	patients	as	either	alive	or	dead	on	discharge.	I	defined	two	classifiers	







































relative	 risks.	 Data	 are	 described	 as	 a	 percentage	 of	 the	 total	 (actual	 numbers)	 or	 the	 median	


































































































































































is	highlighted	by	Figure	3.4,	 though	a	more	complex	 relationship	 is	 seen	when	mortality	 is	plotted	
against	combinations	of	admission	Ur:Cr	ratio	and	its	in-hospital	change	(Figure	3.5).	
	







































































3.9).	 This	was	 similar	 to	 the	 cross-validation	 AUROC	 of	 79.6%,	 confirming	 its	 validity.	 The	 training	




















tpr:	 True	 Positive	 Rate	 (Sensitivity);	
fpr:	 False	 Positive	 Rate	 (1	 –	
Specificity);	 the	 dots	 represent	


















results	 represent	the	 largest	analysis	 to	date	that	explores	the	association	of	Ur:Cr	with	 in-hospital	






a	normal	Ur:Cr	on	admission.	A	high	Ur:Cr	 ratio	 status	was	strongly	associated	with	 increased	LoS.	





















Reductions	 in	Ur:Cr,	when	 the	 ratio	 at	 admission	was	 >80,	 probably	 reflect	 effective	 intervention,	
though	 I	 am	unable	 to	 describe	 the	 granularity	 of	 such	 interventions.	 It	 is	 likely	 that	 treatment	of	
dehydration	 and	 sepsis	 (alone	 or	 in	 combination)	 might	 play	 a	 dominant	 role	 in	 generating	 this	
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and	may	 represent	 opportunities	 to	 improve	 patient	management.	 Use	 of	 the	 Ur:Cr	 ratio	 and	 its	
trajectory	 in	 order	 to	 highlight	 patients	 at	 risk	 may	 provide	 guidance	 for	 interventions.	 Such	
interventions,	proposed	 in	 the	UK’s	National	 Institute	 for	Health	and	Care	Excellence	guidelines	on	






It	 is	also	the	 first	study	that	examines	the	relationship	between	Ur:Cr	on	admission	and	 its	change	








Nonetheless,	 this	 study	 does	 have	 limitations.	 The	 data	was	 collected	 from	 hospitals	 which	when	
compared	to	the	national	average	had	higher	quality	ratings	(CQC	and	standardised	mortality	ratio)	
than	the	England	average;	 this	could	 introduce	bias	 into	 the	results.	However,	 this	bias,	 if	 it	exists,	




second	 test.	 In	 identifying	 cases	 of	 AKI,	 baseline	 creatinine	was	 defined	 as	 the	 earliest	 blood	 test	
performed	within	24	hours	of	hospital	admission;	however,	since	these	analyses	were	carried	out,	a	




















to	 treat.	 Building	 care	 pathways	 that	 continuously	 track	 hydration	 status	 in	 patients,	 and	 have	
interventions	 to	 maintain	 hydration,	 would	 be	 simple	 and	 require	 relatively	 few	 resources.	 Such	





datasets	 with	 multiple	 non-numerical	 categorical	 values	 was	 extremely	 memory-intensive	 and	












variables	 and	 grouping	 patients	 into	 known	 categories	 (chronic	 kidney	 disease	 stage,	 method	 of	
admission,	ethnicity,	etc.)	to	highlight	both	the	variability,	and	complexity	of	patient	outcome	when	
these	additional	variables	are	used	to	aid	in	risk	classification.	I	then	consolidate	all	available	a	priori	
information	 (including	pre-hospital),	 as	well	 as	 the	dynamic	 change	 in	all	 the	 raw	blood	 results,	 to	
create	an	 interpretable	ML	model	 to	determine	 risk	of	poor	outcome	 (death	or	 renal	 replacement	
therapy)	 in	 hospital.	 This	 approach	 is	 applied	 to	my	 entire	 dataset,	 and	 specifically	 addresses	 the	
occurrence	of	(and	outcome	from)	AKI,	a	condition	defined	by	the	dynamic	change	of	just	one	variable:	








AKI	 just	 uses	 the	 dynamic	 change	 in	 one	 variable,	 creatinine,	 for	 its	 diagnosis.	 A	 defined	 rise	 in	 a	
patient’s	serum	creatinine,	from	their	baseline	has	been	used	to	severity	stage	a	patient’s	AKI.	These	
















of	 the	 current	 serum	 creatinine	 with	 a	 calculated	 baseline	 serum	 creatinine.	 The	 baseline	 serum	
creatinine	is	defined	as	either	the	minimum	level	in	the	last	seven	days,	or	the	median	in	the	last	8–



























The	 dataset	 described	 in	 Chapter	 2	 was	 used	 for	 these	 analyses.	 In	 brief,	 I	 collated	 continuous	
electronically	 stored	 data	 from	 all	 adults	 (18	 years	 and	 over)	 admitted	 to	 fourteen	UK	NHS	 acute	




56,	 57,	 84,	 87,	 88,	 98	 and	 99).136	 Also	 excluded	 were	 those	 known	 to	 be	 dependent	 on	 renal	
replacement	therapy	prior	to	admission,	identified	by	ICD10	code	Z99.2	or	by	their	elective	admission	
for	RRT	alone	(one-day	planned	admission	and	OPCS4	codes	X40,	X40.1,	X40.2,	X40.3,	X40.8	and	X40.9).	






























the	 trigger	 route	 for	 that	AKI	 stage.	The	maximum	AKI	 stage	attained	 for	each	patient	during	each	

























results	 from	 the	 previous	 365	 days,	 the	 first	 set	 of	 admission	 blood	 results,	 and	 those	 that	 first	
triggered	 an	 AKI	 stage,	 with	 the	 administrative	 information	 available	 at	 those	 times.	 The	 a	 priori	








(ML50,	 ML33,	 ML25),	 selected	 to	 produce	 positive	 predictive	 values	 (PPV)	 of	 1:2,	 1:3	 and	 1:4	
respectively	on	the	train	data.	
	




is	 scaled	 so	 that	 the	 sum	 adds	 to	 100,	 with	 higher	 numbers	 indicating	 stronger	 influence	 on	 the	
response.’	
	
The	 software	 used	 was	Microsoft	 R	 Open	 3.2.5	 (Microsoft,	 USA:	 https://mran.microsoft.com/rro),	































































































































































Number	of	admissions	 1,139,220	 832,910	 	
Male	 425,528		(47.1%)	 355,442	(42.7%)	 	
Age	(median	(IQR)	 67	(47–80)	years	 56	(37–69)	years	 <1	x	10
-2	
Length	of	stay	(median	(IQR))	 4	(1–9)	days	 0	(0–4)	days	 <1	x	10
-2	
Drrt	(%)	 53,206	(5.9%)	 9,031	(1.1%)	 <1	x	10
-2	
CKD	Stage	 Frequency	(percentage	of	Emergency,	Planned)	
None	to	Mild	(CKD	0–2)	 470,517	(52.1%)	 556,547	(66.8%)	 <1	x	10
-2	
Moderate	(CKD	3)	 157,655	(17.5%)	 85,453	(10.3%)	 <1	x	10
-2	
Severe	(CKD	4–5)	 39,941	(4.4%)	 23,419	(2.8%)	 <1	x	10
-2	
Unknown	(CKD	?)	 234,474	(26%)	 167,491	(20.1%)	 <1	x	10
-2	
Co-Morbidities	–	ICD10	code	 Frequency	(percentage	of	Emergency,	Planned)	
Essential	(primary)	hypertension	 I10	 303,446	 26.6%	 136,075	 16.3%	 <1	x	10
-2	
Type	2	diabetes	mellitus	 E11	 144,337	 12.7%	 55,674	 6.7%	 <1	x	10
-2	
Chronic	ischaemic	heart	disease	 I25	 130,211	 11.4%	 48,815	 5.9%	 <1	x	10
-2	








Z864	 86,855	 7.6%	 34,458	 4.1%	 <1	x	10
-2	




Z867	 80,334	 7.1%	 32,419	 3.9%	 <1	x	10
-2	
Heart	failure	 I50	 80,118	 7.0%	 10,684	 1.3%	 <1	x	10
-2	
Asthma	 J45	 75,699	 6.6%	 35,592	 4.3%	 <1	x	10
-2	
Smoking	 F17	 68,267	 6.0%	 23,266	 2.8%	 <1	x	10
-2	




Z921	 57,213	 5.0%	 24,221	 2.9%	 <1	x	10
-2	
Chronic	kidney	disease	 N18	 56,625	 5.0%	 21,040	 2.5%	 <1	x	10
-2	
Depressive	episode	 F32	 54,119	 4.8%	 14,018	 1.7%	 <1	x	10
-2	
Other	hypothyroidism	 E03	 51,859	 4.6%	 21,345	 2.6%	 <1	x	10
-2	










F10	 37,550	 3.3%	 3,381	 0.4%	 <1	x	10
-2	
Presence	of	orthopaedic	joint	implants	 Z966	 33,363	 2.9%	 16,687	 2.0%	 <1	x	10
-2	
Presence	of	aortocoronary	bypass	graft	 Z951	 30,427	 2.7%	 10,747	 1.3%	 <1	x	10
-2	
Presence	of	electronic	cardiac	devices				 Z950	 28,586	 2.5%	 7,503	 0.9%	 <1	x	10
-2	
















Z866	 17,347	 1.5%	 6,028	 0.7%	 <1	x	10
-2	












C90	 5,381	 0.5%	 34,780	 4.2%	 <1	x	10
-2	
Myeloid	leukaemia	 C92	 4,116	 0.4%	 24,218	 2.9%	 <1	x	10
-2	
		
A	 total	 of	 6,343,530	 serum	 creatinine	 tests	 were	 performed	 during	 hospital	 admissions,	 with	 the	
median	creatinine	per	admission	being	1	(IQR:	1	to	3).	For	emergency	admissions,	there	was	a	total	of	













First	AKI	 Cr	48h		 Cr:BCr	 BCr	 Cr	 Ur	 Na	 K	 Hb	 Plts	 WCC	 MCV	
RDW	




	 0.44	 0.37	 0.61	 0.34	 -0.03	 0.21	 0.00	 -0.03	 0.01	 0.00	 -0.02	




	 	 	 0.83	 0.48	 0.00	 0.20	 -0.12	 -0.09	 -0.04	 0.00	 -0.01	
Creatinine	
(Cr)	
	 	 	 	 0.63	 -0.02	 0.29	 -0.10	 -0.07	 -0.02	 0.01	 0.00	
Urea	(Ur)	 	 	 	 	 	 0.02	 0.34	 -0.05	 -0.04	 0.06	 0.02	
0.08	




	 	 	 	 	 	 	 -0.05	 0.13	 0.04	 0.01	 0.03	
Hemoglobin	
(Hb)	
	 	 	 	 	 	 	 	 0.09	 0.04	 0.07	 -0.26	
Platelets	
(Plts)	








	 	 	 	 	 	 	 	 	 	 	 -0.15	
4.4.2	Epidemiology	/	Variation	in	Prevalence	and	Progression	of	AKI	Admissions	
AKI	 occurred	 in	 170,596	 (8.6%)	 admissions,	 representing	 122,696	 (13%)	 unique	 patients.	Of	 these,	
170,596	admissions	with	AKI,	65,772	(38.6%)	were	diagnosed	with	AKI	on	their	first	creatinine	test	in	
hospital,	indicating	community-acquired	AKI.		Tables	4.4,	4.5	and	4.6	show	the	AKI	prevalence	by	ethnic	
group,	 and	 by	 month,	 day	 and	 method	 of	 admission	 respectively.	 The	 highest	 proportion	 of	 AKI	




of	 AKI	 admissions	 occurred	 over	 winter	 (January	 (9.2%)	 and	 December	 (9.2%))	 and	 the	 weekend	
(Saturday	(10.3%)	and	Sunday	(10.5%)).	Analysing	the	data	by	method	of	admission,	AKI	was	almost	
twice	as	common	in	emergency	as	in	planned	admissions	(10.7%	(122,346)	vs	5.8%	(48,240),	p<1	x	10-








































































































































































































































































































































































































































































































































































































































































































































































false-negative-AKI.	 The	 Drrt	 rate	 in	 these	was	 higher	 than	 in	 those	 cases	 in	which	 a	 fall	 in	 serum	




(10,053;	 0.5%)	 in	 hospital.	 Of	 the	 64,296,	 55.7%	 (35,832:	 died=30,047;	 renal	 replacement	
therapy=7,476)	had	suffered	AKI.	Overall,	Drrt	occurred	in	21%	(35,832)	of	those	who	developed	AKI,	






























1	 15,114	 111,163	 13.6	%	
(13.4–13.8)	
42.2	 65.1	 1	in	7.4	
2	 8,101	 29,683	 27.3	%	
(26.8–27.8)	
22.6	 80.3	 1	in	3.7	
3	 12,617	 29,740	 42.4	%	
(41.9–43)	
35.2	 83.5	 1	in	2.4	





1	 24,528	 131,324	 18.7	%	
(18.5–18.9)	
68.5	 71.2	 1	in	5.4	
2	 5,493	 21,537	 25.5	%	
(25–26.1)	
15.3	 79.6	 1	in	3.9	
3	 5,811	 17,725	 32.8	%	
(32.1–33.5)	
16.2	 80.4	 1	in	3.1	




	 	 	 	 	 	 	
ML25	 na	 na	 25	%	 na	 99.6	 21.3	 1	in	4	
ML33	 na	 na	 33.3	%	 na	 95.3	 49.4	 1	in	3	













































































































not	dissimilar	 from	 those	 reported	worldwide	 (AKI	mortality	 =	23.3%).84	 Finally,	 I	 confirmed	 that	 a	





AKI	 algorithm.	 This	 is	without	 a	 doubt	 a	 positive	 incremental	 improvement	 in	 the	management	of	
patients	with	renal	injury.	However,	I	have	demonstrated	there	is	room	for	a	further	significant	step	
change	improvement,	as	there	are	weaknesses	in	the	KDIGO-based	NHSE-AKI	algorithm.	Outcome	is	
dependent	 not	 just	 on	 the	 AKI	 stage,	 but	 also	 on	 the	 route	 within	 the	 algorithm	 by	 which	 it	 is	





















My	 study	 does	 have	 some	 limitations.	 A	 small	 number	 of	 admissions	 received	 renal	 replacement	
therapy	without	AKI	having	been	diagnosed	by	 the	algorithm	 (2,577).	Of	 these,	 2,019	actually	had	
existing	 CKD-4/5,	 and	may	 thus	 already	 have	 been	 dependent	 on	 renal	 replacement	 therapy.	 This	
suggests	a	possible	failure	of	appropriate	in-hospital	diagnostic	coding.	Alternatively,	acute	on	chronic	
kidney	 injury	associated	with	a	<1.5-fold	 increase	 in	 creatinine	 from	 the	baseline	 (and	 thus	no	AKI	
diagnosis)	 may	 yet	 have	 led	 to	 renal	 replacement	 therapy.	 However,	 as	 these	 patients	 were	 not	
classified	as	having	AKI,	 they	were	excluded	 from	the	AKI	analysis,	 regardless	of	whether	 the	 renal	
replacement	therapy	was	planned	or	due	to	undiagnosed	AKI	(which	cannot	be	discriminated	between	
from	my	dataset).	It	is	also	worthy	of	note	that	patients	transferred	to	another	hospital	were	excluded,	
which	 would	 not	 have	 been	 known	 a	 priori.	 Nor	 were	 all	 ‘detrimental	 outcomes’	 (length	 of	 stay,	
hospital	 readmission	 or	 development	 of	 CKD)	 modelled.	 Future	 studies	 might	 also	 expand	 my	
definition	of	‘false-negative-AKI’	to	include	cases	where	creatinine	did	fall	(leading	to	the	lack	of	an	AKI	














































thus,	an	 ideal	EWSC	would	be	applicable	 to	all	hospitalised	patients,	 regardless	of	 their	method	of	
admission	or	disease	state.	Preferably,	such	an	EWSC	would	be	able	to	risk-stratify	patients	as	early	in	
their	hospitalisation	as	possible,	 i.e.	on	admission.	In	addition,	the	capability	to	provide	an	updated	
prediction	 of	 in-hospital	 mortality	 once	 initial	 treatment	 has	 taken	 place	 would	 also	 help	 target	
resources	to	those	patients	who	are	either	at	continued	risk	or	have	deteriorated	since	admission.	As	
discussed	 in	Chapter	1	 (Section	1.4.4),	 there	have	been	attempts	at	building	such	 laboratory-based	








d) Lack	 of	 context	 sensitive	 information:	 they	 account	 for	 neither	 the	 date	 of	 a	 patient’s	







































The	 following	 results	 were	 collated	 from	 each	 admission:	 the	 first	 and	 second	 sodium	 (mmol/L),	
potassium	(mmol/L),	urea	(mmol/L),	creatinine	(µmol/L),	haemoglobin	(g/L),	platelet	(109/L),	mean	cell	
















































































































































with	 the	 smallest	mean	 cross-validation	 log	 loss).	 The	 range	 of	 the	 hyper-parameters	 for	 the	 grid	

































































































(3.5%)	 and	 December	 (3.9%).	 Weekend	 admissions	 had	 higher	 mortality	 when	 compared	 with	


























































































































































































































































Essential	(primary)	hypertension	 I10	 431,609	 23.03	%	
Angina	Pectoris	 I20	 60,181	 3.21	%	
Chronic	ischaemic	heart	disease	 I25	 174,610	 9.32	%	
Atrial	fibrillation	or	flutter	 I48	 151,808	 8.1	%	
Heart	Failure	 I50	 79,226	 4.23	%	
Personal	history	of	diseases	of	the	circulatory	system	 Z867	 111,968	 5.97	%	
Secondary	malignant	neoplasm	of	lymph	nodes	 C77	 25,351	 1.35	%	
Secondary	malignant	neoplasm	of	other	and	unspecified	sites	 C79	 37,953	 2.02	%	
Multiple	myeloma	and	malignant	plasma	cell	neoplasms	 C90	 37,608	 2.01	%	
Myeloid	leukaemia	 C92	 25,511	 1.36	%	
Other	hypothyroidism	 E03	 70,281	 3.75	%	
Type	2	diabetes	mellitus	 E11	 199,260	 10.63	%	
Obesity	 E66	 32,739	 1.75	%	
Disorders	of	lipoprotein	metabolism	and	other	lipidaemias	 E78	 155,255	 8.28	%	
Mental	and	behavioural	disorders	due	to	use	of	alcohol	 F10	 43,076	 2.30	%	
Smoking	 F17	 94,122	 5.02	%	
Depressive	episode	 F32	 66,164	 3.53	%	
Epilepsy	 G40	 35,559	 1.90	%	
Other	chronic	obstructive	pulmonary	disease	 J44	 99,895	 5.33	%	
Asthma	 J45	 113,837	 6.07	%	




Personal	history	of	malignant	neoplasm	of	digestive	organs	 Z850	 21,552	 1.15	%	








Presence	of	electronic	cardiac	devices	 Z950	 34,612	 1.85	%	
Presence	of	aortocoronary	bypass	graft	 Z951	 38,428	 2.05	%	




























































Emergency,	 elective,	 and	 maternity	 admissions	 accounted	 for	 71.9%,	 20.6%	 and	 4%	 of	 the	 total	





respectively.	 The	median	 values	 of	 all	 the	 second	 blood	 tests,	 including	 the	 number	 with	missing	
values,	are	shown	in	Table	5.14;	of	note	are	the	proportion	of	admissions	with	no	results	for	platelets,	





The	 in-hospital	mortality	 rates	 for	each	group	of	admissions	 is	 shown	 in	Tables	5.9	 to	5.12.	Within	
ethnic	categories,	the	highest	mortality	rates	(significantly	higher	than	in	all	other	ethnicities)	occurred	
in	 the	 ‘Not	 Stated’	 and	 ‘British’	 categories,	 at	 7.6%	and	6.5%	 respectively.	Mortality	by	method	of	
admission	(Emergency:	7.6%;	Elective:	1.5%;	and	Maternity:	0.04%;	p<0.01)	substantiates	the	view	that	
patients	admitted	as	an	emergency	are	more	likely	to	die	than	those	admitted	via	either	the	elective	
or	 the	maternity	 method.	 The	 ‘Other’	 method	 of	 admission	 (the	 bulk	 of	 which	 consisted	 of	 non-
emergency	inter-hospital	transfers)	had	a	small	prevalence	(1.6%),	but	the	highest	mortality	rate	of	all,	



























































































































































































































































Essential	(primary)	hypertension	 I10	 241,620	 29.78%	
Angina	Pectoris	 I20	 34,132	 4.21%	
Chronic	ischaemic	heart	disease	 I25	 109,753	 13.53%	
Atrial	fibrillation	or	flutter	 I48	 102,601	 12.65%	
Heart	Failure	 I50	 61,157	 7.54%	
Personal	history	of	diseases	of	the	circulatory	system	 Z867	 64,779	 7.98%	
Secondary	malignant	neoplasm	of	lymph	nodes	 C77	 8,263	 1.02%	
Secondary	malignant	neoplasm	of	other	sites	 C79	 16,522	 2.04%	
Multiple	myeloma	and	malignant	plasma	cell	neoplasms	 C90	 7,309	 0.90%	
Myeloid	leukaemia	 C92	 6,847	 0.84%	
Other	hypothyroidism	 E03	 39,889	 4.92%	
Type	2	diabetes	mellitus	 E11	 118,876	 14.65%	

























Smoking	 F17	 47,218	 5.82%	
Depressive	episode	 F32	 34,828	 4.29%	
Epilepsy	 G40	 18,547	 2.29%	
Other	chronic	obstructive	pulmonary	disease	 J44	 65,617	 8.09%	
Asthma	 J45	 54,683	 6.74%	















Presence	of	electronic	cardiac	devices	 Z950	 21,788	 2.69%	
Presence	of	aortocoronary	bypass	graft	 Z951	 23,444	 2.89%	











































was	67	years.	However,	 for	 female	admissions	 this	was	32	years;	on	 further	 investigation,	 this	was	






older	 patients	 underwent	more	 investigations	 in	 hospital.	 The	 burden	 of	 admissions	 also	 changed	
between	 the	 cohorts	 when	 the	 patients’	 method	 of	 admission	 was	 examined.	 The	 prevalence	 of	
emergency	 admissions	 rose	 from	 57.6%	 to	 71.9%	 (p<0.01)	 from	 the	 Admission	 to	 the	
Two_Tests_Cohort,	 with	 concurrent	 falls	 in	 elective	 admissions	 and	 maternity	 admissions.	 This	
indicates	that	elective	admissions,	when	compared	with	emergency	admissions,	are	more	likely	to	be	
discharged	after	their	first	set	of	blood	results.	Patients	who	have	a	second	set	of	blood	tests	are	sicker	
than	 those	who	 just	 have	 one	 set.	 This	 is	 demonstrated	 by	 the	 increase	 in	 the	 prevalence	 of	 co-





In	 the	Admission_Cohort,	 regarding	 admissions	 over	 the	weekend	 vs	weekdays,	 the	mortality	 rate	
difference	in	these	groups	fell	to	non-clinically	significant	levels	(1.4%	to	0.3%)	when	only	emergency	






admitted	 over	 the	 winter	 (December	 and	 January)	 vs	 the	 summer	 (May–September).	 Patients	
admitted	 as	 emergencies	 had	 higher	 rates	 of	 dying	 in	 hospital	 than	 either	 elective	 or	 maternity	




been	 pre-arranged	 transfers	 between	 critical	 care	 units,	 or	 the	 movement	 of	 especially	 complex	
patients	to	or	from	specialist	care	centres,	 i.e.	the	sickest	patients	 in	hospital.	Further	 investigation	
would	need	to	be	carried	out	to	explore	this	further.	
	
The	 ML-Admission	 and	 ML-Two-Tests	 models	 are	 by	 far	 the	 most	 accurate	 models	 to	 date	 for	
predicting	a	patient’s	risk	of	dying	in	hospital.	Not	only	do	the	models	when	used	together	enable	an	
initial	prediction	to	be	made	at	the	point	of	admission,	but	they	also	allow	for	a	modification	of	this	

















in	 the	underlying	data,	 there	are	a	 lot	 less	patients	 in	 the	Two_Tests_Cohort	admitted	as	elective/	
maternity	vs	emergency.	As	emergency	patients	have	a	higher	mortality,	the	probability	of	mortality	
gleaned	 from	 Method	 of	 Admission	 decreases	 slightly	 (as	 the	 probability	 of	 patient	 being	 an	
emergency	 increases),	 this	 is	also	probably	the	reason	that	Urea	at	First	Aki	stage	 in	ML-AKI	 (Table	
4.10)	has	a	higher	importance	than	Method	of	Admission.	Albumin	however,	despite	being	absent	in	
>21.1%	 (Admission_Cohort)	and	34.5%	 (Two_Tests_Cohort)	 cases	still	have	a	high	 influence	on	 the	
model	result,	reinforcing	the	complexity	of	the	contribution	of	a	variable	to	the	model.	It	is	important	
to	note	that	the	scaled	variable	 importance	 is	purely	based	on	mathematical	analysis	of	 the	model	
structure	 itself,	 and	 does	 not	mean	 a	 higher	 or	 lower	 value	 results	 in	 increased	 risk,	 just	 that	 the	
defined	variable	influences	the	final	result	of	the	model	more	than	(or	less	than	others).		
	























































(and	 recovery)	 of	 a	 patient	 after	 certain	 operations,	 and	 now	 tracking	 this	 has	 become	 simple.	
Monitoring	 could	 also	 continue	 once	 a	 patient	 is	 discharged	 home,	 with	 no	 additional	 complex	
hardware,	 allowing	 for	 a	 home	 based	 EWSC	 on	 the	 most	 vulnerable	 patients.	 In	 fact,	 there	 are	
companies	providing	such	services	in	the	community	already	such	as	Sentrian.	Sentrian	allows	for	the	































I	 conceived,	 led,	managed,	and	wrote	part	of	 the	software	code	 for	 the	Patient	Rescue	technology	
platform.	I	was	supported	by	a	core	team	consisting	of	a	part-time	software	developer	(Simon	Brown),	























result	 data	 is	 part	 of	 the	 laboratory	 information	management	 system	 (LIMS).	 Co-morbidity	 data	 is	
stored	within	an	electronic	health	record	(if	such	exists)	or	in	a	business	intelligence	database	(used	to	
create	the	NHS	Trust’s	CDS.APC	submission	to	HSCIC	(NHS	England)).	Admission	and	discharge	from	







These	 host	 information	 systems	 are	 based	 on	 old	 database	 architectures	 and	 optimised	 for	 the	















Level	 Seven	 International146,	 an	 American	 National	 Standards	 Institute	 accredited	 standards-
developing	organisation	dedicated	to	providing	a	comprehensive	framework	and	related	standards	for	
the	exchange,	integration,	sharing	and	retrieval	of	electronic	health	information	that	supports	clinical	

































relevant	 information	 relating	 to	 the	 outcome	of	 the	model’s	 result	must	 be	 communicated	 to	 the	




As	 the	demonstration	of	 ‘Patient	Rescue’	was	 focused	on	AKI,	 I	 created	a	 report	 that	 incorporated	
information	 that	a	nephrologist	would	 request	 if	 referred	a	patient	diagnosed	with	AKI.	The	actual	
























1. Data	 from	 different	 sources	 are	 mapped	 to	 a	 canonical	 form	 before	 being	 analysed	 and	
persisted.	 This	 overcomes	 the	 issue	 of	 variations	 in	 the	 terminology	 and	 meaning	 of	
information	sent	(which	are	allowed	within	the	HL7	framework).	






b. The	 database	 schema	 is	 optimised	 for	 large	 quantities	 of	 data,	 and	 the	 database	
















The	 platform	 uses	 the	 gateway	 component	 of	 the	 open	 source	Mirth	 Connect149	 to	 consume	HL7	

























An	 open-source	 messaging	 framework,	 Rabbit	 MQ150,	 with	 .NET	 extensions	 was	 selected	 for	 the	
Service	 Bus,	 and	 configured/coded	 for	 the	 platform.	 The	 Service	 Bus	 allows	 processes	 to	 post	
information	(for	example,	a	set	of	blood	test	results),	with	metadata	describing	that	information	(for	
example,	the	types	of	blood	tests),	which	is	termed	the	‘topic’.	Other	processes	can	subscribe	to	listen	





































from	data	stored	 in	SQLServer.	 It	also	allows	 these	 reports	 to	be	sent	via	email.	The	Alert	Services	
trigger	SSRS	to	create	and	send	AKI	alerts	to	practitioners	via	email.	These	emails	contain	complex	PDF	
(portable	 document	 format)	 reports,	 including	 patient	 history	 (in	 tabular	 and	 chart	 form),	
demographics	and	identifiers.	
The	Patient	Rescue	reporting	system	provides	two	levels	of	insight:		




















vi) Further	 Advice:	 Additional	 analyses	 are	 performed	 on	 the	 entire	 patient	 dataset	 to	
determine	if	there	are	any	other	abnormalities,	or	whether	further	investigations	should	
be	requested	to	exclude	specific	pathologies.	









from	 the	 dashboard,	 and	 the	 full	 AKI	 report	 (as	 described	 above)	may	 be	 viewed.	 It	 will	 also	
continuously	populate	a	 live	AKI	performance	 report.	This	presents	data	on	 the	number	of	AKI	

















Since	 the	 start	 of	 my	 PhD,	 there	 have	 been	 a	 number	 of	 initiatives/solutions,	 in	 the	 UK	 and	
internationally,	 that	 are	 tackling	 the	 problem	 of	 real	 time	 integration	 of	 disparate	 healthcare	
repositories	and	enabling	live	analytics.	The	most	prominent	in	the	UK	being	Datawell,	a	Connected	
Health	Cities	project	of	the	Northern	Health	Science	Alliance.	Datawell	builds	on	a	platform	developed	




Health	division	within	 IBM	is	also	building	on	 its	cognitive	computing	solutions	to	gain	 insight	 from	
existing	 data,	 both	 within	 the	 hospital	 but	 also	 from	 public	 research	 repositories	 (e.g.	 pubmed).	
Overall,	this	is	a	rapidly	advancing	field,	and	I	believe	in	just	a	few	years,	it	will	be	commonplace	for	IT	







Name Dƌ͘EĞƉŚƌŽŶ<ŝĚŶĞǇƐŽŶ Sex M Age ϲϱ
DOB 0ϭͬϬϭͬϭϵϱϬ
Location
Hospital Number ϵϵϵϵϵϵ  Hospital ^ƚ͘ůƐĞǁŚĞƌĞΖƐ
ĐƵƚĞ<ŝĚŶĞǇhŶŝƚ
AKI alert time: 19 January 2015 ϭϲ:00:00Stage of AKI: 3
Background risk factors 
Neoplasms
Further advice͗
WůĂƚĞůĞƚƐůŽǁ͗ Consider microangŝŽƉĂƚŚǇͲƉĞƌĨŽƌŵ blood film, reticulocytes and haptoglobins
Lactate dehydrogenase: no results available in the last 48 hours
IŵŵƵŶŽŐůŽďƵůŝŶƐĂƌĞĂďŶŽƌŵĂů: consider myeloma
     Radiology report date: 1ϳ January 2015 ϭϬ͗ϬϬ
US RENAL TRACT͗Both kidneys are enlarged͕ with increasedreflectivity in keeping with a nephritic process. There is a  complexcyst at the left upper pole . 
No other renalůĞƐŝŽŶŝĚĞŶƚŝĨŝĞĚ͘
AKI Complications
Urea is high: 29.5 mmol/LͲ ĂƐƐĞƐƐĨŽƌ uraemia
C reactive protein is high: 33 mg/LͲ ĐŽŶƐŝĚĞƌ sepsis
WŚŽƐƉŚĂƚĞŝƐŚŝŐŚ͗Ϯ͘ϴϵŵŵŽůͬ>




Hospitalised	 patients	 are	 at	 risk	 of	 deteriorating	 and	 suffering	 an	 AE	while	 in	 hospital.	 These	 AEs	
















































these	 I	 selected	universally	 collected	 variables.	 The	data	 sources	were	1)	CDS.APC	 (Commissioning	




























AKI,	as	defined	using	 the	NHS	England	Algorithm,	 to	be	prevalent	 in	hospitalised	patients	affecting	
8.6%	(170,596	/	1,972,130)	of	all	admissions	with	an	in-hospital	creatinine	result;	this	figure	is	lower	
than	those	reported	previously	(14.7%	in	northern	Europe,	20%	worldwide).	Also,	amongst	patients	








heart	 disease:	 26.2%,	 angina:	 24%;	 or	 presence	 of	 electronic	 cardiac	 devices:	 28.8%),	 chronic	
obstructive	 pulmonary	 disease	 (30.8%)	 and	 malignancy	 (36%).	 Increasing	 AKI	 stages	 (1	 to	 3)	 are	
designed	to	risk-stratify	AKI	patients	by	worsening	outcomes.	Although	the	Drrt	rates	increased	with	
each	AKI	stage	(AKImax	Stage	1:	13.6%;	Stage	2:	27.3%;	Stage	3:	42.4%),	 I	 found	significant	variation	





















‘Other’	 method	 of	 admission	 (the	 bulk	 of	 which	 were	 made	 up	 of	 non-emergency	 inter-hospital	
transfers)	while	accounting	for	only	2.1%	of	admissions	had	the	highest	mortality	rate	of	all,	at	9%.	The	





underway	 led	 by	 the	Department	 of	Health	 and	NHS	 England	 to	 increase	 the	 provision	 of	 doctors	
available	over	the	weekends,	citing	that	this	may	mitigate	the	so	called	weekend	effect.	My	analyses,	
highlight	that	in-hospital	mortality	varies	to	a	greater	degree	by	the	season	(rather	than	the	day	of	the	
week)	of	admission.	There	could	be	multiple	 causes	 for	 such	an	 increase.	Although	not	 specifically	
analysed,	 I	 believe	 that	 a	 rise	 in	 acute	 infective	 respiratory	 diseases	 (e.g.	 viral	 and	 bacterial	





I	 next	 explored	 the	 benefits	 of	 assessing	 patients	 at	 different	 time	 points	 in	 their	 hospital	 stay	




million	 admissions,	 43.28%	 (811,268)	 remained	 in	 hospital	 to	 undergo	 a	 second	 set	 of	 blood	 tests	
(Two_Tests_Cohort).	The	mortality	in	this	group	rose	from	3.14%	to	6.1%	(Emergency	7.6%;	Elective:	
1.5%;	 and	 Maternity:	 0.04%),	 and	 the	 median	 length	 of	 stay	 rose	 from	 2	 to	 6	 days.	 The	
Two_Test_Cohort	patients,	when	compared	to	the	Admission_Cohort,	were	also	older	(median	age	
increased	from	60	to	66);	comprised	of	more	emergency	admissions	(prevalence	increased	from	57.6%	










test	 results	 and	 administrative	 (demographics,	 comorbidity,	 method	 of	 admission,	 etc.)	 data.	 The	
development	 comprised	 two	 key	 parts.	 First,	 I	 created	 various	 ML	 models	 (using	 the	 RF	 and	 GB	





























































there	 are	 56%	 fewer	 patients	 than	 the	 total	 who	 were	 admitted	 to	 hospital	
(Admission_Cohort),	 and	 these	 remaining	 patients	 are	 distinctly	 different,	 being	 older	 and	
sicker	 (mortality	 rate	 6.1%).	 Additionally,	 as	 some	 time	 has	 elapsed	 between	 the	 first	 and	
second	sets	of	blood	tests,	it	is	reasonable	to	expect	that	some	treatment	or	intervention	to	
improve	 the	 patient’s	 outcome	 has	 been	 initiated.	 At	 this	 stage,	 a	mortality	 risk	 of	 33.3%	










medical	 literature,	 and	 provides	 an	 opportunity	 to	 substantially	 improve	 the	 recognition	 of	 the	
deteriorating	(or	at	risk	of	death)	patient.	
	
An	 exciting	 challenge	 encountered	during	 the	 course	 of	 this	 PhD	 research	was	 exploring	 the	most	
effective	 way	 to	 apply	 these	 advanced	 patient	 AE	 detection	models	 within	 clinical	 care,	 and	 thus	
positively	affecting	patient	care.	As	no	such	technology	platform	exists	that	allows	such	models	to	be	
implemented	across	diverse	hospitals	with	different	clinical	care	systems,	I	created	my	own:	‘Patient	
Rescue’.	 Using	 a	 cloud-based	 platform,	 and	 complying	 with	 all	 legal	 and	 information	 governance	
requirements,	Patient	Rescue	was	developed	by	myself,	 leading	a	core	team	comprising	a	software	
developer	 (Simon	 Brown),	 an	 NHS	 information	 analyst	 (Ani	 Dwarakanath),	 and	 a	 project	manager	
(Prashant	 Lele).	 To	 fund	 this	 innovative	 development,	 I	 successfully	 competed	 for	 the	 Regional	
Innovation	Fund,	and	was	awarded	£183,000	from	NHS	England,	for	the	team	and	the	software.	The	
challenges	we	faced	and	our	solutions	are	described	in	Chapter	6,	but	in	summary,	we	overcame	the	
live	 access,	 analytic	 and	 communication	 problems,	 and	 successfully	 created	 a	modular	 technology	
framework	based	on	a	mixture	of	open-source	and	Microsoft	components.	Patient	Rescue	was	based	
on	 a	 ‘Publisher-Subscriber’	 architecture,	 and	was	 successfully	 integrated	within	 three	hospitals.	 By	
analysing	millions	of	data	points,	milliseconds	after	they	were	generated,	Patient	Rescue	generated	





Since	 the	 start	 of	 my	 PhD,	 there	 have	 been	 a	 number	 of	 initiatives/solutions,	 in	 the	 UK	 and	















the	 hospital	 but	 also	 from	 public	 research	 repositories	 (e.g.	 pubmed).	 Overall,	 this	 is	 a	 rapidly	
advancing	 field,	 and	 I	 believe	 in	 just	 a	 few	 years,	 it	 will	 be	 commonplace	 for	 IT	 solutions	 to	 be	
augmenting	 the	 intelligence	 of	 doctors	 (and	 other	 healthcare	 professionals)	 and	 enabling	 better	
quality	of	patient	care.			
	
For	 future	work,	 there	are	still	numerous	challenges	 to	be	 faced.	Medicine	needs	 to	be	more	data	
driven,	rather	than	paying	lip	service	to	an	evidence	based	medicine	approach,	healthcare	data	needs	











to	 clinicians	 and	what	 clinical	 decisions/interventions	 could	 be	 automated	 is	 key	 to	 the	 successful	






















care	at	some	point	 in	 their	hospital	 stay	 (141,500).	This	poor	quality	care	 is	cited	as	a	contributing	
factor	 to	 their	 ultimate	 poor	 outcome	 (in	 this	 case	 death),	 in	 at	 least	 half	 of	 all	 these	 patients.	
Implementation	of	such	a	system	of	advanced	algorithms	and	real	time	identification	with	appropriate	
intervention,	could	theoretically	save	anywhere	between	70,750	to	141,500	lives	in	England	alone	(the	
figure	 probably	 being	 closer	 to	 70,750	 as	 some	 patients	 would	 probably	 be	 palliative,	 or	 no	
interventions	 could	 change	outcome).	 The	potential	 impact,	both	nationally	 and	 internationally,	of	
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Accident	 and	 Emergency	 Department	 to	 receive	 treatment	 from	 the	 accident	 and	
emergency	service.	
Out	Patient	Commissioning	Data	Set	Types	
CDS	 V6-2	 Type	 020	 -	 Outpatient	
CDS	
Carries	the	data	for	an	Outpatient	Attendance	or	a	cancelled/missed	APPOINTMENT.	






CDS	 V6-2	 Type	 120	 -	 Admitted	
Patient	 Care	 -	 Finished	 Birth	
Episode	CDS	




CDS	 V6-2	 Type	 130	 -	 Admitted	








CDS	 V6-2	 Type	 140	 -	 Admitted	






CDS	 V6-2	 Type	 150	 -	 Admitted	
Patient	 Care	 -	 Other	 Birth	 Event	
CDS	
Applies	 to:	NHS	 funded	home	births	and	all	other	birth	events	which	are	not	NHS-
funded,	 either	 directly	 or	 under	 an	 NHS	 SERVICE	 AGREEMENT.	 The	 data	 in	 these	
records	originates	from	birth	notification	records	and	requires	only	a	limited	data	set	
to	be	completed	
CDS	 V6-2	 Type	 160	 -	 Admitted	






CDS	 V6-2	 Type	 170	 -	 Admitted	








CDS	 V6-2	 Type	 180	 -	 Admitted	








CDS	 V6-2	 Type	 190	 -	 Admitted	
Patient	Care	-	Unfinished	General	
Episode	CDS	












Commissioning	Data	 Set	 records	are	 required	 for	 all	Unfinished	Birth	and	Delivery	
Episodes	as	at	midnight	on	31	March	each	year.	
Elective	Admission	List	Commissioning	Data	Set	Types	-	End	Of	Period	Census	Types	
CDS	 V6-2	 Type	 030	 -	 Elective	









CDS	 V6-2	 Type	 040	 -	 Elective	





time-scale	has	been	agreed	with	 the	 recipient.	 It	 covers	ELECTIVE	ADMISSION	LIST	
ENTRIES	under	the	care	of	a	CONSULTANT,	MIDWIFE	or	NURSE,	where	an	appropriate	
MAIN	SPECIALTY	CODE	and	TREATMENT	FUNCTION	CODE	exists.	
CDS	 V6-2	 Type	 050	 -	 Elective	









CDS	 V6-2	 Type	 060	 -	 Elective	
Admission	 List	 -	 Event	 During	
Period	(Add)	CDS	
Is	used	to	make	an	initial	report	that	an	ELECTIVE	ADMISSION	LIST	ENTRY	has	been	
added	 to	 the	Health	Care	Provider's	ELECTIVE	ADMISSION	LIST.	 It	 covers	ELECTIVE	
ADMISSION	 LIST	 ENTRIES	 under	 the	 care	 of	 a	 CONSULTANT,	MIDWIFE	 or	 NURSE,	
where	 an	 appropriate	 MAIN	 SPECIALTY	 CODE	 and	 TREATMENT	 FUNCTION	 CODE	
exists.	Elective	Admission	List	Event	During	Period	CDS	Types	are	intended	for	those	
ORGANISATIONS	 who	 have	 the	 capability	 to	 implement	 transaction-based	




CDS	 V6-2	 Type	 070	 -	 Elective	




LIST	 ENTRIES	 under	 the	 care	 of	 a	 CONSULTANT,	 MIDWIFE	 or	 NURSE,	 where	 an	
appropriate	MAIN	SPECIALTY	CODE	and	TREATMENT	FUNCTION	CODE	exists.	Elective	
Admission	List	Event	During	Period	CDS	Types	are	intended	for	those	ORGANISATIONS	







CDS	 V6-2	 Type	 080	 -	 Elective	
Admission	 List	 -	 Event	 During	
Period	(Offer)	CDS	
Is	used	 to	 report	 that	an	OFFER	OF	ADMISSION	has	been	made	to	 the	PATIENT.	 It	
covers	 ELECTIVE	 ADMISSION	 LIST	 ENTRIES	 under	 the	 care	 of	 a	 CONSULTANT,	
MIDWIFE	or	NURSE,	where	an	appropriate	MAIN	SPECIALTY	CODE	and	TREATMENT	
FUNCTION	CODE	exists.	Elective	Admission	List	Event	During	Period	CDS	Types	are	





CDS	 V6-2	 Type	 090	 -	 Elective	
Admission	 List	 -	 Event	 During	
Period	 (Available	 or	 Unavailable)	
CDS	




those	 ORGANISATIONS	 who	 have	 the	 capability	 to	 implement	 transaction-based	




CDS	 V6-2	 Type	 100	 -	 Elective	
Admission	 List	 -	 Event	 During	
Period	 (Old	 Service	 Agreement)	
CDS	
Is	used	to	report	 to	 the	previous	Commissioner	 that	 the	ELECTIVE	ADMISSION	LIST	
ENTRY	 is	 now	 the	 responsibility	 of	 a	 new	 Commissioner.	 It	 covers	 ELECTIVE	
ADMISSION	 LIST	 ENTRIES	 under	 the	 care	 of	 a	 CONSULTANT,	MIDWIFE	 or	 NURSE,	
where	 an	 appropriate	 MAIN	 SPECIALTY	 CODE	 and	 TREATMENT	 FUNCTION	 CODE	
exists.	Elective	Admission	List	Event	During	Period	CDS	Types	are	intended	for	those	
ORGANISATIONS	 who	 have	 the	 capability	 to	 implement	 transaction-based	




CDS	 V6-2	 Type	 110	 -	 Elective	
Admission	 List	 -	 Event	 During	




covers	 ELECTIVE	 ADMISSION	 LIST	 ENTRIES	 under	 the	 care	 of	 a	 CONSULTANT,	
MIDWIFE	or	NURSE,	where	an	appropriate	MAIN	SPECIALTY	CODE	and	TREATMENT	
FUNCTION	CODE	exists.	Elective	Admission	List	Event	During	Period	CDS	Types	are	











































































constantly	 analysing	 individual	 patient	 data	 to	 identify	 these	 patients	 prior	 to	 them	
deteriorating.	Implementation	of	a	working	system	(not	part	of	this	study),	will	help	clinicians	
make	 the	 right	 decisions	 on	 further	 investigations,	 referral	 to	 specialist	 teams	 and	 specific	
treatment	earlier	than	what	currently	occurs.	
	
The	 study	 will	 analyse	 anonymised	 data	 from	 all	 patients	 who	 have	 been	 admitted	 and	
subsequently	discharged	from	a	range	of	hospitals.	The	data	(without	patient	name,	date	of	
birth,	address,	hospital	number,	etc)	will	be	extracted	from	existing	hospital	databases,	and	





the	 need	 for	 emergency	 surgery,	 or	 death)	 are	 commonplace	 in	 hospitalised	patients,	 and	








previously	 shown	 that	 applying	 novel	multivariate	 approaches	 to	 this	 dataset	 can	 improve	
sensitivity	 for	 detecting	 SAEs	 by	 5%	 (while	 conserving	 specificity)	 for	 each	 trigger	 value	 of	
NEWS.	This	approach,	though,	is	inherently	limited	by	the	use	of	‘snapshot’	vital	signs,	without	
reference	 to	 separate	prospective	 risk	 classification.	As	 such,	a	patient	 is	only	 identified	as	
being	‘at	risk’	when	physiological	derangement	is	already	causing	significant	compromise-	a	
point	at	which	the	window	of	opportunity	for	effective	clinical	 intervention	may	already	be	
closing.	 Here,	 I	 propose	 a	 research	 programme	 focused	 on	 a	 new	 and	 complementary	
approach.	
	












inpatient	 blood	 tests,	 married	 with	 data	 relating	 to	 co-morbidities.	 My	 preliminary	 data	















range	 and	 determine	 those	 interrelationships	 that	 represent	minimal	mortality	 i.e.	
optimal	health.	
2. To	 identify	 clusters	 of	 patients	 with	 above-average	mortality	 and	 characterize	 the	
specific	 relationships	 between	 their	 blood	 results	 and	 their	 associated	 clinical	
conditions.	























- A	 local	 collaborator	will	 be	 identified	 at	 each	 individual	NHS	 trust.	 The	 local	 collaborators	will	
normally	be	from	the	Biochemistry	and	Intensive	Care	Departments.	
- The	 data	 extraction	 and	 anonymisation	 will	 be	 carried	 out	 by	 the	 information	 teams	 at	 the	
respective	NHS	trusts	using	existing	hospital	systems.	The	process	is	simple	and	straightforward	
within	existing	hospital	IT	infrastructure.	
- Each	NHS	 Trust's	 Research	 and	Development,	 Information	Governance	 and	 Caldicott	 Guardian	
teams	will	approve	the	anonymised	data	extraction.	
- No	patient	identifiable	data	will	leave	the	NHS	trust	or	be	shared	with	the	researchers.	

































The	 data	 to	 be	 interrogated	 consist	 of	millions	 of	 data	 points,	 distributed	 over	 a	 high	 number	 of	
dimensions.	 The	 dimensions	 themselves	 represent	 a	mixture	 of	 discrete	 and	 continuous	 variables,	
some	of	which	have	 temporal	 components.	This	volume	and	complexity	 requires	a	combination	of	
three	methodologies	to	achieve	the	inferential	goals:	
1. Building	on	my	preliminary	service	evaluation/audit	highlighting	 the	problems	with	 the	current	
“normal	range”,	I	shall	use	probabilistic	pattern-recognition	(supervised	learning)	to	identify	the	
inter-relationships	 between	 routine	 haematological/biochemical	 data	 that	 result	 in	 minimum	
mortality	 and	 morbidity.	 Patients	 will	 be	 subdivided	 into	 demographic-,	 co-morbidity-	 and	
	
178	
intervention-based	 groups.	 Support	 Vector	 Machines	 will	 then	 be	 used	 for	 classification	 and	
regression.	
2. Utilising	 neural	 networks	 (unsupervised	 learning)	 and	 the	 subsequent	 identified	 clusters,	 I	 will	










this	 by	 initially	 dividing	 the	 datasets	 into	 the	 previously	 identified	 clusters	 and	 then	 use	 a	
generative	model,	(Hidden	Markov	Model),	of	blood	results	v1:t	with	the	outcome	label	cT	.	Non-
standard	approaches	will	be	utilised	to	train	these	models.	 In	addition,	separate	models	will	be	










Gaussian	 variational	 approximations	 for	 inference	 in	 large-scale	 Bayesian	 linear	models	 as	well	 as	








performance	 computing	 systems	 (e.g.	 LEGION	 and	 GPU	 clusters),	 secure	 data	 transmission	 and	
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